GlassScriptPhysician profile
Andrew John Herman
NPI 1801859004
$4,383.10
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $938 · 2020: $786 · 2021: $1,255 · 2022: $1,403.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $709.35 | 2019-2022 | |
| Amarin Pharma, INC. | $603.43 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $569.81 | 2019-2022 | |
| Pfizer INC. | $427.50 | 2019-2022 | |
| Abbvie INC. | $338.93 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $251.04 | 2021-2022 | |
| Novo Nordisk INC | $232.09 | 2019-2022 | |
| Lilly USA, LLC | $182.36 | 2020-2022 | |
| Allergan, INC. | $175.59 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $141.67 | 2019-2022 | |
| Glaxosmithkline, LLC. | $127.95 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $103.49 | 2020-2022 | |
| Novartis Pharmaceuticals Corporation | $86.32 | 2019-2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $85.80 | 2022 | |
| Astellas Pharma US INC | $72.14 | 2019-2021 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $67.06 | 2020-2021 | |
| Biohaven Pharmaceuticals, INC. | $51.75 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $37.48 | 2022 | |
| Amgen INC. | $36.61 | 2019-2021 | |
| Eisai INC. | $21.44 | 2021 | |
| Biogen, INC. | $19.39 | 2022 | |
| Electromed, INC. | $15.63 | 2022 | |
| Corcept Therapeutics | $13.20 | 2022 | |
| Circassia INC. | $13.07 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Herman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.